Company Filing History:
3 out of 98 
2 out of 4 Years Active: 1998-1999
Title: Eivind Hovig: Innovator in Cancer Research
Introduction
Eivind Hovig is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of cancer research, particularly through his innovative work on oligonucleotides. With a total of 3 patents, Hovig's inventions focus on methods to inhibit metastatic cancer.
Latest Patents
Hovig's latest patents include the development of CAPL-specific oligonucleotides and methods of inhibiting metastatic cancer. These patents disclose synthetic oligonucleotides that have a nucleotide sequence complementary to CAPL nucleic acid. Additionally, they outline methods for inhibiting the expression of the CAPL gene, which can be crucial in the fight against metastatic cancer.
Career Highlights
Throughout his career, Eivind Hovig has worked with prominent organizations such as Hybridon, Inc. and the Norwegian Radium Hospital Research Foundation. His work in these institutions has allowed him to advance his research and contribute to significant breakthroughs in cancer treatment.
Collaborations
Hovig has collaborated with esteemed colleagues, including Oystein Fodstad and Olav Engebraaten. These partnerships have further enriched his research and innovation in the field.
Conclusion
Eivind Hovig's contributions to cancer research through his patents and collaborations highlight his role as a key innovator in the medical field. His work continues to inspire advancements in the treatment of metastatic cancer.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.